News from btg plc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

23 Jul, 2019, 07:00 BST Recommendations for Personalised HCC Treatment With Y90 TheraSphere™ Published by an International Multidisciplinary Group

BTG plc (LSE: BTG), a global healthcare company, today announced consensus recommendations for personalised treatment for hepatocellular carcinoma...


16 Jul, 2019, 11:00 BST BTG to Invest in Chinese Medical Isotope Diagnosis and Treatment Company Chengdu New Radiomedicine Technology

BTG International Asia Limited, a subsidiary of BTG plc (LSE: BTG) announced today that it has agreed to invest RMB 76million (approximately USD...


29 Apr, 2019, 15:00 BST Venous Leg Ulcer Registry Shows Promising Results for Varithena® Use in Wound Healing

BTG plc (LSE: BTG), the global specialist healthcare company, today highlighted the VIEW VLU Registry interim study results, presented at the...


07 Mar, 2019, 15:00 GMT BTG Crossing Devices are Highlighted at the CTO Summit in NY

BTG plc (LSE: BTG), the global healthcare company, exhibited the BTG Crossing Devices portfolio at the Chronic Total Occlusion (CTO) Summit in New...


05 Mar, 2019, 19:00 GMT New Research Validates Clinical Value of Treating Copperhead Envenomation with CroFab®

BTG plc (LSE: BTG), the global healthcare company, announced that research published today in PLOS ONE establishes the Patient-Specific Functional...


14 Feb, 2019, 12:00 GMT A Retrospective Study of Medicare Claim Data Shows Patients Treated with Voraxaze® had Shorter Hospitalizations and Lower Mortality

BTG plc (LSE: BTG), the global healthcare company, today announced the publication of data showing that cancer patients with presumed methotrexate...


05 Feb, 2019, 07:00 GMT NHS England Expands Loco-regional Treatment Options for Colorectal Cancer Patients With Metastatic Disease [1]

BTG plc (LSE: BTG), a global healthcare company, today announced that the NHS Specialised Services Commissioning Committee has agreed that, effective ...


21 Jan, 2019, 21:00 GMT Australian Patient Treated With DC Bead LUMI™, the First Commercially Available Radiopaque Drug-Eluting Bead

BTG plc (LSE: BTG), a global specialist healthcare company, today announced the treatment of an Australian patient with DC Bead LUMI™, a...


08 Jan, 2019, 14:00 GMT BTG and OMNY Partner to Improve Treatment of Snake Bite Victims

Distributed ledger technology is a game changer for managing stock levels of critical antidote BTG, the global healthcare company, is partnering with ...


21 Dec, 2018, 14:00 GMT BTG Announces National Reimbursement for TheraSphere® in France

An estimated 500 patients per year in France could be eligible for treatment with TheraSphere® BTG plc (LSE: BTG), a global specialist healthcare...


20 Sep, 2018, 07:00 BST BTG Announces Global Launch of the ICEfx™ Cryoablation System

The ICEfx™ Cryoablation system is a compact and powerful console, offering predictable, reliable performance with seamless therapy delivery and...


16 Nov, 2017, 12:00 GMT New Consensus Guidelines Provide Specific Recommendations for Use of Voraxaze® in Patients with Delayed Methotrexate Clearance

BTG plc (LSE: BTG), the global specialist healthcare company, announces the publication of new consensus guidelines for use of Voraxaze®...


09 Oct, 2017, 07:00 BST First Patient Treated With Microscopic Beads Pre-loaded With a Targeted Cancer Drug and Visible on CT Scans

Researchers from the UCL Cancer Institute and the specialist healthcare company BTG plc (LSE: BTG) have begun the first clinical trial of an...


13 Sep, 2017, 12:00 BST Vistogard® and Voraxaze® Added to Revised Guidelines for Stocking of Antidotes in US Hospitals

BTG plc (LSE: BTG), the global specialist healthcare company, announces the inclusion of two of its oncology-related antidote products in the revised ...


21 Aug, 2017, 12:00 BST BTG and SIO Expand Immuno-Oncology / Interventional Oncology Grant Programme

BTG plc (LSE: BTG), a global specialist healthcare company, and the Society of Interventional Oncology (SIO), an international organisation working...


13 Jun, 2017, 12:05 BST New Study Shows Patients Treated With CroFab® Have Improved Recovery From Copperhead Envenomation

A study sponsored by BTG plc (LSE: BTG), the global specialist healthcare company, has been recently published in the Annals of Emergency Medicine...


10 Jun, 2017, 13:30 BST New Study Shows IO Loop™ Improves Patient Follow-up, Engagement and Satisfaction Following Treatment With TheraSphere®

Study shows patients treated with TheraSphere® maintain quality of life throughout 90 day post-treatment period BTG plc (LSE: BTG), a global...


07 Jun, 2017, 12:00 BST SIO Announces First Grants in Interventional Oncology / Immuno-Oncology Research Programme

The Society of Interventional Oncology (SIO), a global organization working to nurture and support interventional oncology worldwide, and global...


20 Apr, 2017, 07:00 BST First European Patients Treated With DC Bead LUMI™ Radiopaque Drug-Eluting Beads

BTG plc (LSE: BTG), a global specialist healthcare company, today announced the treatment of the first patients in the EU with DC Bead LUMI™. Two...


07 Mar, 2017, 07:00 GMT BTG Announces CE Mark Certification for DC Bead LUMI™, the First Commercially Available Radiopaque Drug-Eluting Bead in the EU

DC Bead LUMI™ provides real-time visible, lasting confirmation of bead location during and post-embolisation of hypervascular tumours in the liver...


15 Feb, 2017, 13:00 GMT BTG and Society of Interventional Oncology to Explore Role of Minimally Invasive Therapies in Immuno-oncology

BTG plc (LSE: BTG), the global specialist healthcare company, today announced a collaboration with the Society of Interventional Oncology (SIO), a...


05 Dec, 2016, 07:00 GMT PneumRx® Coils Included in New Global Clinical Guidelines and Given Positive Recommendation to Treat Severe Emphysema Patients in France

BTG plc (LSE: BTG), the global specialist healthcare company, today announces the inclusion of treatment with PneumRx® Coils in guidelines for the...


19 Oct, 2016, 07:00 BST First Patient in Malaysia Receives TheraSphere™ radioembolisation Therapy

BTG plc (LSE: BTG), an international specialist healthcare company, today announced that the first patient in Malaysia was treated with TheraSphere™...


14 Oct, 2016, 07:00 BST BTG and Mirada Medical Announce CE Mark Certification for Simplicit90Y™ Dosimetry Software in Europe

New easy-to-use software designed to improve the planning of 90Y selective internal radiation therapy (SIRT) treatment for patients with liver cancer ...


09 Sep, 2016, 07:00 BST BTG Launches βETA™ Radiation Safety Programme, to Reduce the Risk of Radiation Exposure for Healthcare Professionals and Patients

BTG plc (LSE: BTG), an international specialist healthcare company, today announced the launch of the βETA™ Radiation Safety Programme, a new...